Merck, Amgen Share Losses Lead Dow's Nearly 350-Point Fall

Dow Jones
Yesterday

DJ Merck, Amgen Share Losses Lead Dow's Nearly 350-Point Fall

This article was automatically generated by MarketWatch using technology from Automated Insights.

Dragged down by losses for shares of Merck and Amgen, the Dow Jones Industrial Average is declining Monday afternoon.

Shares of Merck (Merck & Co. Inc.) and Amgen (Amgen Inc.) have contributed to the index's intraday decline, as the Dow (Dow Jones Industrial Average) was most recently trading 342 points, or 0.7%, lower.

Merck's shares are down $2.51 (2.4%) while those of Amgen are off $8.18, or 2.4%, combining for an approximately 66-point drag on the Dow.

Other components contributing significantly to the decline include Goldman Sachs (Goldman Sachs Group Inc.), McDonald's (McDonald's Corp.), and IBM (International Business Machines Corp.).

A $1 move in any of the benchmark's 30 components equates to a 6.16-point swing.

Data source: Dow Jones Market Data, FactSet. Data compiled December 1, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

December 01, 2025 14:29 ET (19:29 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10